echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Fesenyuskabi and Viagra reached a strategic cooperation to establish a joint venture

    Fesenyuskabi and Viagra reached a strategic cooperation to establish a joint venture

    • Last Update: 2020-02-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Fresenyuskabi will establish a strategic partnership with VIFor Pharma to provide more products and services for patients with iron deficiency anemia in China Under the strategic cooperation agreement, fresenyuskabi will establish a joint venture with Viagra to provide special brand management, market access and medical affairs resources for the intravenous injection product portfolio for the treatment of iron deficiency anemia Through this strategic cooperation, freseniuskabi will promote its intravenous injection product portfolio for the treatment of iron deficiency anemia, and cooperate with medical professionals to treat other indications, including kidney diseases "This collaboration with Viagra marks an important new stage in our business development, and this initiative will bring more patients the benefits of blood management and treatment," said mats henriksson, President and CEO of freseniuskabi, referring to the strategic cooperation Weifu pharmaceutical has the world's leading product line for the treatment of iron deficiency anemia Combined with our long-term efforts and development in China and Asia, we believe that it can better meet the needs of Chinese patients and medical staff " Etienne jornod, executive chairman of Viagra, also mentioned: "we are pleased to announce this important strategic cooperation Whether from the perspective of business or value sharing, freseniuskabi is an ideal partner, whose solid foothold in China can help us to benefit the public in the targeted treatment field of intravenous iron product portfolio " It is reported that China has the largest population of iron deficiency anemia (IDA) in the world, with an incidence of about 20% As the world leader in iron deficiency management, Weifu pharmaceutical is committed to providing patients with high-quality and innovative treatment options We will combine the leading product portfolio of Viagra in the treatment of iron deficiency anemia with the leading position of freseniuskabi in the Chinese market for many years to provide better medical solutions for medical staff to benefit more Chinese patients.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.